(Q38481486)

3 September 2017

Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

3 September 2017

0 references

1 reference

1 reference

Beom-June Kwon

1

1 reference

3 September 2017

Dong-Bin Kim

2

1 reference

3 September 2017

Sung-Won Jang

3

1 reference

3 September 2017

Ki-Dong Yoo

4

1 reference

3 September 2017

Keun-Woong Moon

5

1 reference

3 September 2017

Byung Ju Shim

6

1 reference

3 September 2017

Seo-Hee Ahn

7

1 reference

3 September 2017

Eun-Ju Cho

8

1 reference

3 September 2017

Tae-Ho Rho

9

1 reference

3 September 2017

Jae-Hyung Kim

10

1 reference

3 September 2017

22 September 2010

1 reference

European Journal of Heart Failure

3 September 2017

1 reference

3 September 2017

12

1 reference

3 September 2017

1339-1344

1 reference

3 September 2017

12

1 reference

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

3 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Heart failure and chronic obstructive pulmonary disease: An ignored combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Systolic and diastolic heart failure: differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Diagnosis and differential assessment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

The Seattle Heart Failure Model: prediction of survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Severe pulmonary hypertension and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

Chronic obstructive pulmonary disease in patients admitted with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ157

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ157

1 reference

3 September 2017

1 reference